1. Home
  2. OFG vs MIRM Comparison

OFG vs MIRM Comparison

Compare OFG & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFG
  • MIRM
  • Stock Information
  • Founded
  • OFG 1964
  • MIRM 2018
  • Country
  • OFG United States
  • MIRM United States
  • Employees
  • OFG N/A
  • MIRM N/A
  • Industry
  • OFG Major Banks
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • OFG Finance
  • MIRM Health Care
  • Exchange
  • OFG Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • OFG 1.9B
  • MIRM 2.5B
  • IPO Year
  • OFG N/A
  • MIRM 2019
  • Fundamental
  • Price
  • OFG $44.64
  • MIRM $52.66
  • Analyst Decision
  • OFG Buy
  • MIRM Strong Buy
  • Analyst Count
  • OFG 3
  • MIRM 9
  • Target Price
  • OFG $46.00
  • MIRM $66.22
  • AVG Volume (30 Days)
  • OFG 263.7K
  • MIRM 456.2K
  • Earning Date
  • OFG 07-17-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • OFG 2.68%
  • MIRM N/A
  • EPS Growth
  • OFG 6.67
  • MIRM N/A
  • EPS
  • OFG 4.18
  • MIRM N/A
  • Revenue
  • OFG $623,009,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • OFG $2.30
  • MIRM $35.83
  • Revenue Next Year
  • OFG $2.61
  • MIRM $16.83
  • P/E Ratio
  • OFG $10.71
  • MIRM N/A
  • Revenue Growth
  • OFG N/A
  • MIRM 69.31
  • 52 Week Low
  • OFG $33.15
  • MIRM $36.17
  • 52 Week High
  • OFG $47.66
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • OFG 66.76
  • MIRM 64.66
  • Support Level
  • OFG $44.08
  • MIRM $49.22
  • Resistance Level
  • OFG $45.05
  • MIRM $53.86
  • Average True Range (ATR)
  • OFG 0.84
  • MIRM 1.57
  • MACD
  • OFG 0.15
  • MIRM 0.08
  • Stochastic Oscillator
  • OFG 84.72
  • MIRM 79.63

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: